Rabies Antiserum Is Fastest Growing Segment Fueling The Growth Of Rabies Antiserum Market

Rabies Antiserum Market



Rabies Antiserum refers to antibody-based biopharmaceutical products used for post-exposure prophylaxis in individuals suspected of exposure to rabies virus. These products provide immediate passive immunity against rabies virus infection and allow time for the patient's own immune system to develop an active immune response upon vaccination. The growing incidence of rabies among domestic and wild animals has boosted the demand for effective post-exposure prophylaxis including antiserum therapies.


Market key trends:
Rabies Antiserum market is driven by rising public awareness about post-exposure prevention of rabies. Government agencies across developing nations are undertaking educational campaigns about stray dog bites and importance of timely treatment. This has resulted in increased demand for rabies immunoglobulins or antiserum from biopharmaceutical companies. Furthermore, ongoing research efforts to develop antiserum products with improved stability at varying temperatures without loss of potency are supporting wider accessibility and availability of rabies post-exposure prophylaxis especially in remote regions.

The global Rabies Antiserum Market Share is estimated to be valued at US$ 1.24 Bn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global rabies antiserum market is segmented into immunoglobulins, monoclonal antibodies, and others. The immunoglobulins segment dominated the market in 2023 and is expected to continue its dominance during the forecast period. Immunoglobulins provide cost-effective treatment against rabies infection making it the preferred choice of treatment for many physicians globally.

Key Takeaways
The global rabies antiserum market is expected to witness high growth, exhibiting CAGR of 3.3% over the forecast period, due to increasing pet adoption and surge in animal bite cases globally.

Regional analysis
North America dominated the global rabies antiserum market in 2023 and is expected to maintain its dominance over the forecast period. Growing pet population and high awareness regarding animal bite treatment in the region is driving the market growth. Asia Pacific is expected to be the fastest growing region due to rising initiatives to control rabies infection in major countries like India and China.

Key players
Key players operating in the rabies antiserum market are CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd., Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, MassBiologics, Serum Institute of India Ltd., Green Cross Corp., Haffkine Bio-Pharmaceutical Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG (China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., Beijing Tiantan Biological Products Co. Ltd.


Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more